Showing results (1-10 of 477) with videos related to
Sort By:
Pageof 48
Therapeutic Drug Monitoring|December 1, 1993
Aluminum neurotoxicity in experimental animalsR T Erasmus, J Savory, M R Wills, et al.Neuropathology and Applied Neurobiology|February 1, 1994
Partial reversal of aluminium-induced neurofibrillary degeneration by desferrioxamine in adult male rabbitsJ Savory, M M Herman, R T Erasmus, et al.Clinical Transplantation|August 1, 1995
Hyperaluminemia associated with liver transplantation and acute renal failureR T Erasmus, J Kusnir, W C Stevenson, et al.Neurotoxicology|April 29, 1998
Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's diseaseJ Savory, Y Huang, M R Wills, et al.Brain Research|January 29, 1996
Quantitative image analysis of temporal changes in tau and neurofilament proteins during the course of acute experimental neurofibrillary degeneration; non-phosphorylated epitopes precede phosphorylationJ Savory, Y Huang, M M Herman, et al.Annals of Clinical and Laboratory Science|January 1, 1993
Long-term oral aluminum administration in rabbits. II. Brain and other organsM R Wills, C D Hewitt, J Savory, et al.Brain Research|January 16, 1995
Tau immunoreactivity associated with aluminum maltolate-induced neurofibrillary degeneration in rabbitsJ Savory, Y Huang, M M Herman, et al.Neuropathology and Applied Neurobiology|February 1, 1991
Aluminium maltol-induced neurocytoskeletal changes in fetal rabbit midbrain in matrix cultureC D Hewitt, M M Herman, M B Lopes, et al.Annals of Clinical and Laboratory Science|January 1, 1993
Long-term oral or intravenous aluminum administration in rabbits. I. Renal and hepatic changesM R Wills, C D Hewitt, B C Sturgill, et al.Environmental Health Perspectives|November 1, 1985
Water content of aluminum, dialysis dementia, and osteomalaciaM R Wills, J SavoryPageof 48